BOLT - CIK 0001641281
The table below shows Bolt Biotherapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $11.70M | $7.21M | $10.81M | $9.24M | $27.38M |
| Short-term investments | $15.80M | $40.12M | $91.38M | $159.64M | $158.84M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $30.26M | $50.81M | $105.71M | $172.75M | $189.16M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $1.25M | $3.14M | $4.96M | $6.45M | $6.16M |
| Goodwill | - | - | - | - | - |
| Total assets | $56.75M | $99.63M | $159.78M | $227.81M | $307.72M |
| Accounts payable | $1.44M | $1.51M | $2.99M | $3.59M | $3.57M |
| Total current liabilities | $8.44M | $15.86M | $20.46M | $23.12M | $21.33M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $30.24M | $42.43M | $47.04M | $56.30M | $57.60M |
| Retained earnings | -$460.78M | -$427.40M | -$364.29M | -$295.09M | -$206.99M |
| Total equity | $26.50M | $57.20M | $112.74M | $171.51M | $250.12M |